GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)
Summary
- Eligibility
- for people ages 2-20 (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Paul Harmatz, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Paul Harmatz, MD
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 211 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Azafaros A.G.
- ID
- NCT05109793
- Study Type
- Observational
- Participants
- Expecting 75 study participants
- Last Updated